SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-15-000135
Filing Date
2015-02-17
Accepted
2015-02-17 17:19:15
Documents
2
Group Members
DOMINIQUE SEMONMERLIN NEXUS IV, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 2 ss416897_sc13ga.htm SC 13G/A 172420
2 JOINT FILING AGREEMENT ss416897_ex99b.htm EX-99.B 19353
  Complete submission text file 0000947871-15-000135.txt   193346
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Subject) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53249 | Film No.: 15624392
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A